You Position: Home > Paper

Evidence and experience in management of neonatal COVID-19

( views:0, downloads:0 )
Author:
No author available
Journal Title:
Chinese Journal of Perinatal Medicine
Issue:
12
DOI:
10.3760/cma.j.cn113903-20221010-00883
Key Word:
新型冠状病毒;新型冠状病毒肺炎;传染病控制;循证医学;婴儿,新生;SARS-CoV-2;COVID-19;Communicable disease control;Evidence-based medicine;Infant, newborn

Abstract: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has mutated multiple times since the first report in December 2019 and is still spreading globally. A variant of SARS-CoV-2, Omicron, was prevalent in Shanghai from March to May 2022. Based on published data and the experience in the management of neonatal COVID-19 cases and infants of mothers with COVID-19 during the pandemic in Shanghai, it is suggested that neonates are infected with SARS-CoV-2 mainly through postnatal horizontal transmission, but rarely through vertical transmission. The risk of SARS-CoV-2 infection in infants born to mothers with COVID-19 is low if quarantine measures are appropriately implemented. Even if they are infected, the risk of severe neonatal COVID-19 is low, but long-term neurological prognosis needs to be followed closely. Human milk feeding without contact is advocated for infants of infected mothers. During the COVID-19 pandemic, attention should also be paid to indirect effect on neonatal health due to possible inadequate medical resources.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn